Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Risk alleles for multiple sclerosis identified by a genomewide study.
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy.
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Episode 60 with Dr. Timothy Vollmer on early, highly effective treatment
Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement
Episode 52 with Dr. David Tabby on migraines in MS
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
20th Annual Rehabilitation In Multiple Sclerosis (RIMS) Conference
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
Petite but Potent
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.
Primary progressive multiple sclerosis-why we are failing.
ACTRIMS-ECTRIMS 2014 -- Day 2, morning
MS Research Roundup: July 17, 2014
An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation.
Episode 46 with Dr. Hans Lassmann on biomarkers in NMO and MS

Pages